ABSTRACT
Subject(s)
Humans , Angiography , Coronary Sinus , Coronary Vessel Anomalies , Coronary Vessels , Diastole , Hemodynamics , Phenobarbital , Prevalence , Retrospective Studies , ROC Curve , SystoleABSTRACT
Coronary artery disease (CAD) remains a leading cause of morbidity and mortality in the world. Although the comprehensive control of cardiovascular disease risk factors has achieved remarkable progress in recent years, the incidence of cardiovascular events is still high after the control of traditional risk factors such as low density lipoprotein cholesterol, blood pressure and blood glucose, collectively referred to as cardiovascular residual risk. Inflammation is a central driver of atherosclerosis and the ultimate rupture of plaque, as well as an important cause of residual cardiovascular risk. Therefore, this article reviews the formation, assessment and treatment of residual inflammatory cardiovascular risk.